Board-Approved for Your 2021 License Renewal Needs.
This program meets the requirements outlined in Section 465.1865, Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida. Upon successful completion of the program, participants will earn a certificate of achievement from the University of Florida Office of Continuing Pharmacy Education.
This program will prepare the pharmacist to test or screen for and treat minor, nonchronic health conditions within the framework of an established written protocol with a supervising physician in accordance with Florida Law. The Test and Treat certification meets the requirements outlined in Section 465.1865, Florida Statutes related to testing or screening for and treatment of minor, nonchronic health conditions.
This activity will provide an overview of the medications used in the treatment of HIV. Specifically, discussed will be the different classes of antiretrovirals, including the mechanism of action, common side effects, drug-drug interactions, and limitations or special considerations which are unique to specific agents.
This continuing Education program will provide guidance to practicing pharmacists and pharmacy technicians on the recognition of human trafficking and what subsequent action steps can be taken to best support victims of trafficking.
Pharmacists and pharmacy technicians are key members of the healthcare team who should understand the risks of medication errors and strategies to prevent them. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.
The validation, dispensing, and counseling of controlled substances by pharmacists is a critical intervention point for resisting opioid misuse and ensuring safe and effective healthcare for the public. This course is approved by the Florida Board of Pharmacy to fulfill the medication errors licensure renewal requirements outlined in Rule 64B16-26.103.